Small Cell Prostate Cancer with Bone Marrow Invasion—A Case Report

Niël, C.; Huys, J; Potter, Christian R. De

doi:10.3109/02841869209088315

Search citation statements

Order By: Relevance

Paper Sections

Select...

Antibody1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1998

2007

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The bones (55%), regional and distant lymph nodes (52%), liver (48%), lungs (34%), bone marrow (12%), soft tissues (11%) and brain (9%) are the commonest metastatic sites [6,10,12,15,20]. It should be noted that SCC of the prostate is more likely than prostate adenocarcinoma to spread to the brain and that brain metastases indicate a poor prognosis.…”

Section: Antibodymentioning

confidence: 96%

Prostate cancer with small-cell morphology: An immunophenotypic subdivision

Petraki

Vaslamatzis

Petraki

et al. 2005

Scandinavian Journal of Urology and Nephrology

View full text Add to dashboard Cite

show abstract

Section: Antibodymentioning

confidence: 96%

Prostate cancer with small-cell morphology: An immunophenotypic subdivision

Petraki

Vaslamatzis

Petraki

et al. 2005

Scandinavian Journal of Urology and Nephrology

View full text Add to dashboard Cite

show abstract

Unusual and Underappreciated: Small Cell Carcinoma of the Prostate

Palmgren

Karavadia

Wakefield

2007

Seminars in Oncology

149

150

View full text Add to dashboard Cite

Genitourinary Small Cell Carcinoma: Determination of Clinical and Therapeutic Factors Associated With Survival

et al. 1998

View full text Add to dashboard Cite

Genitourinary small cell carcinoma has a poor prognosis, which is worse in prostatic than bladder disease. Patient and tumor characteristics were not determinants of survival when prostatic and bladder small cell carcinoma were analyzed individually. For prostatic disease only primary surgical therapy was associated with prolonged survival, while for bladder disease cisplatin chemotherapy was associated with a favorable prognosis. We recommend considering primary surgical therapy for prostatic and cisplatin based chemotherapy for bladder small cell carcinoma.

show abstract

Small Cell Prostate Cancer with Bone Marrow Invasion—A Case Report

Cited by 3 publications

References 3 publications

Prostate cancer with small-cell morphology: An immunophenotypic subdivision

Prostate cancer with small-cell morphology: An immunophenotypic subdivision

Unusual and Underappreciated: Small Cell Carcinoma of the Prostate

Genitourinary Small Cell Carcinoma: Determination of Clinical and Therapeutic Factors Associated With Survival

Contact Info

Product

Resources

About